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Abstract 
Purpose: To study small intestinal absorption of schisadrol A, schisandrol B, schizandrin A and 
schisandrin B in JingNing particles using in situ single-pass intestinal perfusion (SPIP).  
Methods: Absorption rate constant (Ka) and apparent permeability (Papp) of the drugs at different 
concentrations in various parts of rat small intestine (duodenum, jejunum and ileum) were determined 
using SPIP. JingNing particles were also perfused in situ at different pH in the entire rat intestine. 
Ethanol extract of Schisandra chinensis (standard) at low concentration was perfused in the duodenum 
for comparison with extract of JingNing particles.  
Results: The order of apparent permeability of the four lignans was schisandrol A < schisandrol B < 
schizandrin A < schisandrin B. Ka and Papp values of the four lignans in JingNing particles were 
concentration-dependent. Absorption increased in the rank order: ileum > duodenum > jejunum. 
Optimum absorption pH was 6.50. Polygala tenuifolia extract and volatile oil of Rhizoma acori tatarinowii 
significantly (p < 0.05) enhanced the absorption of the four lignans.  
Conclusion: The four lignans were well absorbed in the intestinal tract, particularly the ileum, probably 
through carrier-mediated transport. The alcohol extract of Polygala tenuifolia and volatile oil of Rhizoma 
acori graminei enhanced the absorption of the four lignans. 
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JingNing particles, containing Radix 
Pseudostellariae, Radix Rehmanniae praeparata, 
Schisandra chinensis (Turcz.)Baill, Polygala 
tenuifolia, Rhizoma acori tatarinowii, Poria cocos 
(Schw.), Wolf and Barbary wolfberry fruit, is a 
traditional Chinese medical formula with a long 
history of its use in clinical practice for treating 
attention deficit hyperactivity (ADHD). The 
alcohol extract of Schisandra chinensis fruit is 
one of the components of traditional Chinese 
herbal medicines in the JingNing particles used 
as hepato-protective agents [1,2]. Schisandra 
chinensis fruit has been used for thousands of 
years in the management of insomnia, coronary 
heart disease, skin disorders, depression and 
menopausal symptoms [3,4].  
 
The lignans of Schisandra chinensis fruit can 
enhance concentration and mental performance. 
They are used as adjuvant substances in the 
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treatment of ADHD, Alzheimer’s disease, 
Parkinsonism, and Meniere’s diseases [5]. 
Traditional theories believe that endogenous liver 
wind is associated with ADHA. 
 
Food and Drug Administration (FDA) has 
recognized that the poor drug permeation across 
the intestinal mucosa is one of the common 
causes for drugs absorption failure and low drug 
bioavailability [6,7]. The factors of influencing 
drug absorption contain the physical and 
chemical properties of compounds, such as 
structure, pKa, dosage forms characteristics, etc 
[8].  The majority of drugs are administered 
through the oral route, especially for traditional 
Chinese medicine [9]. The small intestine is the 
main absorption site of drugs. There are some 
methods used to evaluate intestinal absorption 
kinetics. These include in vivo, in vitro and in situ 
methods [10-12]. In situ methods have many 
advantages in that they provide viable intestinal 
mucosa, nerve system and blood flow, as well as 
the expression of specific enzymes and 
transporters [13]. Single-pass intestinal perfusion 
is widely used for studying intestinal absorption 
of drugs due to its high degree of accuracy [14-
17]. This study was aimed at investigating the 
intestinal absorption of four lignans, the main and 
effective ingredients in the Schisandra chinensis 







Schisandrol A, schisandrol B, schizandrin A and 
schisandrin B (purity ≥ 98 %) were bought from 
the National Institutes for Food and Drug Control, 
Beijing, China. JingNing particles were made in 
the laboratory as follows: Schisandra chinensis 
and polygala tenuifolia were extracted with 60 % 
ethanol; essential oils were extracted from 
Rhizomaacori graminei; while the other drugs 
were extracted with water. The culture and 
perfusion solution was Krebs-Ringer (K-R) 
culture solution. Acetonitrile, methanol were 
purchased from Sigma. Double-distilled water 
was used during the entire HPLC procedure. All 
other chemical materials were of analytical grade 




Male Sprague Dawley (SD) rats (mean weight, 
250 ± 20 g) were obtained from the Weitonglihua 
Lab Animal Services Center (Changping, Beijing, 
China). The rats were fasted overnight but 
allowed free access to clean drinking water 
before starting the experiment. The experimental 
procedures were in compliance with the National 
Institutes of Health Guide for Care and Use of 
Laboratory Animals [18] and were approved by 
the Committee on Animal Care and Usage of the 
Beijing University of Chinese Medicine (approval 
no. BUCM-2-2017010101-1001). 
 
Preparation of drug solutions 
 
Sodium dodecyl sulfate (SDS, 0.2 %) was added 
to K-R solution to help dissolve JingNing 
particles. The pH of K-R solution was adjusted to 
6.5 with HCl and NaOH.  
 
Determination of Schisadrol A, Schisandrol 
B, Schizandrin A and Schisandrin B by HPLC 
 
The HPLC system involved a LC-20AT (Japan), 
fitted with an aglient-C18 (250 × 4.6 mm, 5 μm) 
column. The mobile phase were acetonitrile-
water. The detection wavelength for Schisadrol 
A, Schisandrol B, Schizandrin A and Schisandrin 
B was 215 nm. The specificity was described by 
comparing the chromatographs of several 
different types of solutions, including a drug-free 
K-R solution, the intestinal perfusion solution of 
JingNing particles and the reference solution of 
schisandrol A, schisandrol B, schizandrin A and 
schisandrin B [19]. The linearity was established 
by standards sample. The sample was diluted 
into different concentrations [20]. The linearity 
range of this method was 0.40 - 50.20 μg/ml. 
Recovery was expressed as in percentage 
terms. Precision was expressed as relative 
standard deviation (RSD). Intra-day precision 
was measured during one day by analyzing six 
replicates of intestinal perfusion samples, while 
inter-day precision was detected on five 
consecutive days for the intestinal perfusion 
samples. Stability was tested within 24 h. 
 
Studies on drug stability and adsorption   
 
A drug-free intestinal circulation fluid was made 
from a K­R culture solution and perfused in rat 
intestine for 3 h. JingNing particles were 
dissolved in the blank intestinal circulation fluid 
and incubated at 37 oC. Aliquots of 1 mL 
samples were taken out from the intestinal tract 





The perfusion experiment was conducted as 
previously described [14,19]. Briefly, Male SD 
rats were used in situ SPIP studies. Open 
abdomen of the rat along the midline. The 
jejunum was cut from approximately 15 cm 
below the pylorus, and the ileum was cut from 20 
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cm above the caecum. For each section, 10 cm3 
segments were cut. Medicated K-R of a known 
weight was infused into the intestine at a high 
flow rate until the intestine was filled up. Then 
reduced the flow rate for a while. At steady state, 
collect intestinal perfusate samples at different 
time. 
 
Samples from perfusion studies were diluted with 
ethanol (1:1, v: v) and centrifuged for 20 min at 
13000 r/min. The resultant supernatants were 











where Vin and Vout are the respective inlet and 
collected outlet volumes at steady state (The 
gravimetric correction method proposed by 
Sutton et al was used; v is the flow rate (0.20 
ml/min). ρin and ρout are the respective inlet and 
collected outlet concentration at steady state 
(μg/ml), and and  are the length (cm) and 




All values are expressed as mean ± standard 
deviation (SD). SPSS version of 17. 0 software 
was used for statistical analysis, and p < 0.05 




Validation of the HPLC method 
 
The mobile phase was shown in Table 1. 
Schisandrol A, schisandrol B, schizandrin A and 
schisandrin B exhibited major well-resolved 
peaks at approximately 14.5, 17.5, 33.5, 38.5 
min respectively, in HPLC as shown in Figure 1. 
The calibration curve was linear in the range of 
0.40–50.15μg/ml of schisandrol A, 0.40–
50.10μg/ml of schisandrol B, 0.42–52.95μg/ml of 
schizandrin A and 0.40–50.20μg/ml of 
schizandrin B. 
 
The stability and precision of the analytical 
method were within statistical limits (RSD<3 %, 
n=6). These results showed that the HPLC 
method established was suitable [22] (Table 2). 
 
Table 1: Mobile phase of gradient elution 
 
Time 
(min) Acetonitrile (%) 
Water  
(%) 
0 40 60 
20 65 35 
45 75 25 
47 40 60 
57 40 60 
 
Studies on the drug stability and adsorption 
 
The results (Table 2) indicated that the stability of 
the four chemical compounds in blank intestinal 
circulation fluid had RSD < 2 % (n = 6). They 
were deemed to be stable in K-R intestinal 
circulation fluid when intestine was perfused at 
37 oC for 3 h.  
 
Concentration-dependence of absorption 
profiles of the four lignans in JingNing 
particles  
 
The absorption profiles of the four lignans in 
JingNing particles at different concentrations 
(6.4, 12.8 and 25.6 mg/ml) in the duodenum, 
jejunum and ileum were shown in Figure 2 and 
Figure 3. There was a non-linear increase 
corresponding to increases in the concentrations 
of JingNing particles in the intestinal circulation 
fluid. However, the absorptions of the four 
lignans of JingNing particles decreased as their 
concentrations increased. The results showed 
that the transport and absorption of schisandrol 
A, schisandrol B, schizandrin A and Schisandrin 
B would be saturated at high concentrations 
 
Absorptive profiles of the four lignans  
 
Ka and Papp values in the presence of JingNing 
particles in the different intestinal segments were 
shown in Figure 4 and Figure 5. Ileum produced 
the best results (p < 0.05), followed by the 
jejunum, and the duodenum, in that order. 
However, there were no significant differences 
between the jejunum and the duodenum (p < 
0.05). The four lignans were well absorbed in the 
whole intestine. 
 
Influence of other components of JingNing 
on absorption profiles of the four 
components  
 
The alcohol extract of Schisandra chinensis at a 
concentration of 2 mg/ml was chosen as the 
standard. The segment of intestine used was the 
jejunum. The results showed that Polygala 
tenuifolia significantly enhanced the absorption of 
schizandrol A (200 %), schizandrol B (250 %), 
Schisandrin A (380 %) and schisandrin B (280 
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%) in the jejunum. The volatile oil of Rhizoma 
acori tatarinowii enhanced the absorption of 
schizandrol A (300 %), schizandrol B (190 %), 
schisandrin A (340 %) and schisandrin B (240 
%), relative to the standard. However, the other 
components of JingNing had no obvious effects 
on the absorption of the four lignans (Figure 7). 
 
 
Figure 1: Specificity results. K-R solution (a), standard solution (b), sample solution of JingNing particles (c). 
schisandrol A (1), schisandrol B (2), schizandrin A (3), schizandrin B (4) 
 
Table 2: Accuracy, stability and precision of analysis of the four lignans in serosal fluid 
 
Concentration 
level Sample Accuracy Stability (0-24h) Precision (RSD) 
High 
concentration 
Schisandrol A 1.02 0.40% 0.61% 
Schisandrol B 0.99 0.40% 1.04% 
Schizandrin A 0.95 0.65% 0.43 % 
Schizandrin B 0.95 0.40% 0.25 % 
Middle 
concentration 
Schisandrol A 1.03 0.38% 0.44% 
Schisandrol B 1.01 0.38% 1.26% 
Schizandrin A 0.99 0.38% 0.57% 
Schizandrin B 0.97 0.39% 0.35% 
Low 
concentration 
Schisandrol A 1.01 0.29% 0.83% 
Schisandrol B 1.01 0.29% 0.95% 
Schizandrin A 0.96 0.33% 1.27% 
Schizandrin B 0.98 0.19% 1.25% 
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Figure 2: The absorption rate constant (Ka) of the four lignans in duodenum (a), jejunum (b), ileum (c); ☆p < 





The purpose of the research was to determine 
the absorption site of the four lignans in extract of 
JingNing particles as well as the pH for their 
optimum absorption, and the influence of herb-
herb interaction on their intestinal absorption and 
bioavailability.   
 
The results of concentration dependence showed 
a non-linear increase in the transport and 
absorption with different concentrations. With 
increase in concentration, absorption attained 
saturation, indicating that the absorption of the 
four lignans in JingNing particles may be carrier-
mediated. The pH range of the intestinal tract is 5 
- 7. The pH value of intestinal sites decreases in 
the order of ileum>jejunum>duodenum. Thus the 
pH of the ileum is close to 7, which corresponds 
to the optimum pH for the absorption of the four 
lignans in JingNing particles. The lignanoids in 
Schisandra chinensis are the substrates for P-
glycoprotein (P-gp), whose expression in the 
duodenum, jejunum, and ileum was increased. 
The increase may account for the duodenum 
being the best absorption site for Fructus 
schisandrae. However, the ileum was the best 
absorption site for the total lignanoids in JingNing 
particles. The possible reason for this might be 
that some components in Polygala tenuifolia and 
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Rhizoma acori tatarinowii might compete with 
Fructus schisandrae for binding to P-gp.  
 
Studies have shown that absorption is slow when 
Papp <1.8 × 10-4 cm/min, but enhanced when 
Papp >1.2× 10-3 cm/min [23]. The results 
obtained in this study showed that Papp values 
of the four lignans were higher than 1.2 × 10-3 
cm/min, suggesting that they were well absorbed 
in the intestine. 
 
Figure 3: Apparent permeability (Papp) of the four lignans in duodenum (a), jejunum (b), ileum (c); ☆ p<0.05, 
VS. Papp of the low concentration; △ p<0.05, VS. Papp of middle concentration; □ p<0.05, VS. Papp of high 
concentration) 
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Figure 4: Absorption rate constant (Ka) of the four lignans at low (a), middle (b), high concentrations (c); ☆ p < 
0.05, VS. Ka of the duodenum; ○ p < 0.05, VS. Ka of jejunum; ◇ p < 0.05, VS. Ka of ileum 
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Figure 5: Apparent permeabilities (Papp) of the four lignans at the low (a), middle (b), high concentrations (c); ☆ 
p < 0.05, VS. Papp of the duodenum; ○ p < 0.05, VS. Papp of jejunum; ◇ p < 0.05, VS. Papp of ileum 
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Figure 6. Ka (a) and Papp (b) of the four lignans at different pH; ☆p < 0.05, VS. the duodenum; ○ p < 0.05, VS. 
the jejunum; ◇ p < 0.05, VS. the ileum) 
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Figure 7: Ka (a) and Papp (b) of the four lignans in different compatibility groups; ☆ p<0.05, VS. the Schisandra 
group; ○ p<0.05, VS. the Schisandra and polygala group; ◇ p<0.05, VS. the Schisandra and other water 




The results in this study demonstrate that 
Polygala tenuifolia enhances the intestinal 
absorption of the four lignans via inhibition of the 
activity of intestinal P-gp, thereby improving their 
oral bioavailability. Comparison of the intestinal 
absorptions of the four lignans in Schisandra 
chinensis when perfused with a single herb and 
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